Shares of Gilead Sciences rose 6% on Friday after its antiviral drug, remdesivir, became the first and only approved treatment for COVID-19 in the US
Gilead's remdesivir was no better than a placebo at limiting severely ill patients' need for mechanical ventilation, says WHO
Britain has rationed its supplies of the antiviral drug remdesivir and is prioritising COVID-19 patients who need it most in the face of rising demand
Drug Regulatory Authority of Pakistan (DRAP) has issued registration letters for import and manufacturing of remdesivir.
'FDA lately authorise the antiviral drug to treat coronavirus patients'
European health regulator said it would look to fast-track the approval of this antiviral drug as a potential COVID-19 treatment in Europe